IP will be used to pursue further indications for HT-001 Cancer Therapeutic Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, proudly announces advancements in its intellectual property portfolio through the acquisition and expansion of patent applications to its innovative therapeutic pipeline. https://mma.prnewswire.com/media/644804/Hoth_Therapeutics_Logo.jpg These newly secured patents reflect Hoth's commitment to pioneering cutting-edge treatments that […]

(NYSE:VNO), THE PENN DISTRICTVornado's 10 Million SF Campus NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Vornado Realty Trust (NYSE: VNO), along with the U.S. Green Building Council (USGBC), today announced that it has become the first major real estate owner, operator and developer to achieve 100 percent LEED(R) certification across its entire portfolio of

ATP Tower Holdings, LLC (“ATPTH”), Andean Tower Partners Colombia SAS (“Colombia TowerCo”), Andean Telecom Partners Peru S.R.L. (“Peru TowerCo”) and Andean Telecom Partners Chile SpA(“Chile TowerCo” and, together with ATPTH, Colombia TowerCo and Peru TowerCo, “ATP”) announce that ATP has commenced a cash tender offer (the “Tender Offer”) to purchase any and all of ATP's

NovoLINC, a thermal technology startup spun out of Carnegie Mellon University, announced seed funding led by M Ventures, with participation from Foothill Ventures and TDK Ventures. NovoLINC's breakthrough nanocomposite thermal solutions reduce thermal resistance to an industry-record low (< 1mm²-K/W), according to company co-founders, CSO Prof. Sheng Shen and CTO Dr. Rui Cheng. In addition,

(NYSE:ZETA), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Zeta Global Holdings Corp. (NYSE: ZETA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Zeta, you are encouraged

(NasdaqGM:SYM), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Symbotic Inc. (NASDAQ: SYM) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Symbotic, you are encouraged to obtain

(NASDAQ:CPRX), CORAL GABLES, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today reported that its sub-licensee in Japan, DyDo Pharma, Inc., (“DyDo”) has launched FIRDAPSE(R) (amifampridine) Tablets 10 mg in

(NASDAQ:IREN), SYDNEY, Jan. 21, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”) today provided a business update. Key highlights Announcement of $1bn at-the-market facility to support general corporate purposes, including: Expanding capacity to 57 EH/s by H2 2025, with 50 EH/s on track for H1 2025 Initiating

(NASDAQ:NXT), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Nextracker Inc. (NASDAQ: NXT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Nextracker, you are encouraged to obtain

(OTCQB:AIUG),(OTC US:AIUG), LOS ANGELES, Jan. 21, 2025 (GLOBE NEWSWIRE) — AI Unlimited Group Inc. (OTCQB: AIUG), the innovator behind AI-driven platforms spanning fintech, travel, and investment, is thrilled to announce groundbreaking advancements to Lever Student Loans, designed to meet the moment as the student debt landscape shifts under a proactive new administration. The Future of